Institute of Virology, University Hospital, University of Bonn, Bonn, Germany.
Institute of HIV Research, University Duisburg-Essen, Essen, Germany.
Euro Surveill. 2022 Apr;27(14). doi: 10.2807/1560-7917.ES.2022.27.14.2100591.
IntroductionDespite increased use of pre-exposure prophylaxis (PrEP) in Germany, HIV infection rates are not declining and little is known about how this prevention method affects the prevalence of sexually transmitted infections (STI) among men who have sex with men (MSM).AimWe studied, in a large multicentre cohort, STI point prevalence, co-infection rates, anatomical location and influence of PrEP.MethodsThe BRAHMS study was a prospective cohort study conducted at 10 sites in seven major German cities that enrolled MSM reporting increased sexual risk behaviour. At screening visits, MSM were tested for (MG), (NG), (CT) and Treponema pallidum , and given a behavioural questionnaire. With binomial regression, we estimated prevalence ratios (PR) and 95% confidence intervals (CI) for the association of PrEP and STI.ResultsWe screened 1,043 MSM in 2018 and 2019, with 53.0% currently using PrEP. At screening, 370 participants (35.5%) had an STI. The most common pathogen was MG in 198 (19.0%) participants, followed by CT (n = 133; 12.8%), NG (n = 105; 10.1%) and TP (n = 37; 3.5%). Among the 370 participants with at least one STI, 14.6% (n = 54) reported STI-related symptoms. Infection prevalence was highest at anorectal site (13.4% MG, 6.5% NG, 10.2% CT). PrEP use was not statistically significant in adjusted models for STI (PR: 1.10; 95% CI: 0.91-1.32), NG/CT, only NG or only CT.ConclusionsPrevalence of asymptomatic STI was high, and PrEP use did not influence STI prevalence in MSM eligible for PrEP according to national guidelines.
简介
尽管德国越来越多地使用暴露前预防 (PrEP),但 HIV 感染率并未下降,对于这种预防方法如何影响男男性行为者 (MSM) 中的性传播感染 (STI) 流行率知之甚少。
目的
我们在一个大型多中心队列中研究了 STI 的现患率、合并感染率、解剖部位以及 PrEP 的影响。
方法
BRAHMS 研究是一项在德国七个主要城市的 10 个地点进行的前瞻性队列研究,招募了报告性风险行为增加的 MSM。在筛查访问时,MSM 接受了 (MG)、 (NG)、 (CT) 和梅毒螺旋体 (TP) 的检测,并接受了行为问卷。我们使用二项式回归估计 PrEP 和 STI 之间关联的患病率比 (PR) 和 95%置信区间 (CI)。
结果
我们在 2018 年和 2019 年筛查了 1043 名 MSM,其中 53.0% 目前正在使用 PrEP。在筛查时,370 名参与者(35.5%)患有 STI。最常见的病原体是 198 名参与者中的 MG(19.0%),其次是 CT(n=133;12.8%)、NG(n=105;10.1%)和 TP(n=37;3.5%)。在至少有一种 STI 的 370 名参与者中,14.6%(n=54)报告有与 STI 相关的症状。感染流行率在肛门直肠部位最高(MG:13.4%,NG:6.5%,CT:10.2%)。根据国家指南,调整模型中 PrEP 使用在 STI(PR:1.10;95%CI:0.91-1.32)、NG/CT、仅 NG 或仅 CT 方面无统计学意义。
结论
无症状 STI 的患病率很高,并且根据国家指南,PrEP 对符合 PrEP 条件的 MSM 的 STI 流行率没有影响。
J Dtsch Dermatol Ges. 2025-2
Sex Transm Infect. 2024-10-17
Lancet Reg Health Eur. 2023-10-26
Hum Vaccin Immunother. 2023-8-1
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023-9
Pathogens. 2019-12-20
Sex Transm Infect. 2019-6-19
Emerg Infect Dis. 2019-4